Global Upstream Bioprocessing Market Size study, by Product (Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactor Accessories, Bags & Containers, Other Products), by Usage Mode (Multi-use, Single-use), by Mode (In-house, Outsourced), by Application (Monoclonal Antibody Production, Vaccine Production, Cell and Gene Therapy Production, Other Applications), by End-user (Biopharmaceutical Companies, CDMOs and CROs, Research and Academic Institutes) and Regional Forecasts 2022-2032
Global Upstream Bioprocessing Market is valued at approximately USD 9.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.72% over the forecast period 2024-2032. Upstream bioprocessing involves the initial stages of biomanufacturing, focusing on the cultivation and growth of microorganisms or cell cultures. This process includes media preparation, cell culture, and fermentation, where cells are grown in controlled environments to produce biological products such as proteins, vaccines, or antibodies. The primary goal is to create optimal conditions for cell growth and productivity. Upstream bioprocessing is critical for the overall success of biomanufacturing, as it directly impacts the quality and yield of the final product.
The Global Upstream Bioprocessing Market is driven by increasing demand for biopharmaceuticals driven by the high prevalence of chronic diseases. Additionally, the market is bolstered by the increasing adoption of single-use bioprocessing systems and the rising implementation of Process Analytical Technology (PAT), which enhance efficiency and reduce contamination risks. Moreover, continuous advancements in bioprocessing technologies and strategic collaborations aimed at increasing awareness and education related to bioprocessing are expected to drive the market forward. However, the high capital costs associated with upstream bioprocessing systems pose a challenge to market growth.
The key regions considered for the Global Upstream Bioprocessing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is estimated to dominate the upstream bioprocessing market during the forecast period. The region's leadership is supported by advanced technological infrastructure and significant investments in research and development. Furthermore, the market in Asia Pacific is expected to grow at the fastest rate over the forecast period, fueled by increasing demand for biopharmaceuticals and growing investments in the biotechnology sector.
Major market players included in this report are:Corning, Inc.
Danaher Corporation (Cytvia)
Eppendorf AG
Merck KGaA
PBS Biotech, Inc.
Sartorius AG
Thermo Fisher Scientific Inc.
Applikon Biotechnology
Boehringer Ingelheim GmbH
CellGenix GmbH
The detailed segments and sub-segment of the market are explained below:By Product
• Bioreactors/Fermenters
• Cell culture products
• Filters
• Bioreactor accessories
• Bags & containers
• Other products
By Usage Mode
• Multi-use
• Single-use
By Mode
• In-house
• Outsourced
By Application
• Monoclonal antibody production
• Vaccine production
• Cell and gene therapy production
• Other applications
By End-user
• Biopharmaceutical companies
• CDMOs and CROs
• Research and academic institutes
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.